Large-scale testing (Phase 3)UnknownNCT00047138What this trial is testingChemotherapy Before and After Surgery in Treating Children With Wilm's TumorWho this might be right forKidney Cancer University of Leicester 350
Not applicableStudy completedNCT01987726What this trial is testingComprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid TumorsWho this might be right forRecurrent Breast CancerRecurrent Colon CancerRecurrent Rectal Cancer+5 more Ohio State University Comprehensive Cancer Center 150
Testing effectiveness (Phase 2)Ended earlyNCT00853125What this trial is testingSunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Rutgers, The State University of New Jersey 10
Post-approval studies (Phase 4)Ended earlyNCT01266291What this trial is testingSabril for Complex Partial Seizures in Adult Tolerability Study (TS) PatientsWho this might be right forComplex Partial Seizures University of Pennsylvania 1
Testing effectiveness (Phase 2)Ended earlyNCT00318110What this trial is testingMatched Unrelated Donor Transplant for Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Center for International Blood and Marrow Transplant Research 4
Early research (Phase 1)Study completedNCT03002376What this trial is testingAn Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)Who this might be right forMelanoma Regeneron Pharmaceuticals 47
Testing effectiveness (Phase 2)Ended earlyNCT01851174What this trial is testingStudy to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic CancerWho this might be right forPancreatic Carcinoma Non-resectableStage IV Pancreatic Cancer Western Regional Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT03337087What this trial is testingLiposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary CancerWho this might be right forMetastatic Biliary Tract CarcinomaMetastatic Colorectal CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+6 more Academic and Community Cancer Research United 18
Large-scale testing (Phase 3)UnknownNCT00541021What this trial is testingGemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Institut Paoli-Calmettes 104
Testing effectiveness (Phase 2)Study completedNCT00612716What this trial is testingDonor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm Masonic Cancer Center, University of Minnesota 6
Testing effectiveness (Phase 2)Study completedNCT00314678What this trial is testingCisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal CancerWho this might be right forEpithelial Ovarian CancerPrimary Peritoneal Cancer John P. Fruehauf 40
Testing effectiveness (Phase 2)Ended earlyNCT03827850What this trial is testingFGFR Inhibitor in FGFR Dysregulated CancerWho this might be right forLung CancerNSCLCPulmonary Neoplasm+2 more Lung Cancer Group Cologne 22
Very early researchLooking for participantsNCT04005690What this trial is testingTargeted Pathway Inhibition in Patients With Pancreatic CancerWho this might be right forLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+5 more OHSU Knight Cancer Institute 90
Large-scale testing (Phase 3)Study completedNCT00008060What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal CancerWho this might be right forColorectal Cancer Medical Research Council
Testing effectiveness (Phase 2)Ended earlyNCT02489123What this trial is testingEnzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaWho this might be right forAnn Arbor Stage I Mantle Cell LymphomaAnn Arbor Stage II Mantle Cell LymphomaAnn Arbor Stage III Mantle Cell Lymphoma+3 more University of Washington 8
Large-scale testing (Phase 3)Study completedNCT02766335What this trial is testingLung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersWho this might be right forRecurrent Squamous Cell Lung CarcinomaStage IV Squamous Cell Lung Carcinoma AJCC v7 SWOG Cancer Research Network 116
Testing effectiveness (Phase 2)Study completedNCT00002826What this trial is testingDrug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast CancerWho this might be right forBreast Cancer Eastern Cooperative Oncology Group 36
Early research (Phase 1)Ended earlyNCT02550743What this trial is testingBrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group StudyWho this might be right forRectal Cancer howard safran 7
Testing effectiveness (Phase 2)WithdrawnNCT02575508What this trial is testingPan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerWho this might be right forColon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00059813What this trial is testingOblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell CancerWho this might be right forRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 41